BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 24493689)

  • 21. The biochemical basis of metabolism in cancer cachexia.
    Tijerina AJ
    Dimens Crit Care Nurs; 2004; 23(6):237-43. PubMed ID: 15586034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediators of cachexia in cancer patients.
    Argilés JM; López-Soriano FJ; Busquets S
    Nutrition; 2019 Oct; 66():11-15. PubMed ID: 31177056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wasting in cancer.
    Tisdale MJ
    J Nutr; 1999 Jan; 129(1S Suppl):243S-246S. PubMed ID: 9915907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer cachexia: mediators, signaling, and metabolic pathways.
    Fearon KC; Glass DJ; Guttridge DC
    Cell Metab; 2012 Aug; 16(2):153-66. PubMed ID: 22795476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of cancer cachexia.
    Keller U
    Support Care Cancer; 1993 Nov; 1(6):290-4. PubMed ID: 8156245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose tissue dysfunction in cancer cachexia.
    Daas SI; Rizeq BR; Nasrallah GK
    J Cell Physiol; 2018 Jan; 234(1):13-22. PubMed ID: 30078199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of food intake and muscle wasting in cachexia.
    Amitani M; Asakawa A; Amitani H; Inui A
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer anorexia-cachexia syndrome: current issues in research and management.
    Inui A
    CA Cancer J Clin; 2002; 52(2):72-91. PubMed ID: 11929007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding cachexia and excessive weight loss in cancer.
    Hemming L; Maher D
    Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
    Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
    Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia.
    Joshi M; Patel BM
    Mol Cell Biochem; 2022 Jun; 477(6):1709-1723. PubMed ID: 35254613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.